- Home
- TLRY vs BBDC Comparison
TLRY vs BBDC Comparison
Compare TLRY & BBDC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TLRY | BBDC |
|---|---|---|
| Founded | N/A | 2006 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Diversified Financial Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 688.9M | 928.8M |
| IPO Year | 2018 | 2006 |
Fundamental Metrics
Financial Performance| Metric | TLRY | BBDC |
|---|---|---|
| Price | $5.36 | $8.59 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 4 |
| Target Price | ★ $72.33 | $9.56 |
| AVG Volume (30 Days) | ★ 6.8M | 641.2K |
| Earning Date | 04-01-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 11.67% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.25 |
| Revenue | N/A | N/A |
| Revenue This Year | $8.79 | N/A |
| Revenue Next Year | $19.98 | N/A |
| P/E Ratio | ★ N/A | $34.50 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.36 | $7.97 |
| 52 Week High | $15.70 | $9.92 |
Technical Indicators
Market Signals| Indicator | TLRY | BBDC |
|---|---|---|
| Relative Strength Index (RSI) | 36.21 | 45.46 |
| Support Level | $1.12 | $8.39 |
| Resistance Level | $7.01 | $9.08 |
| Average True Range (ATR) | 0.22 | 0.18 |
| MACD | -0.02 | -0.06 |
| Stochastic Oscillator | 19.72 | 22.46 |
Price Performance
Historical ComparisonAbout TLRY Tilray Brands Inc.
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mainly from alcohol.
About BBDC Barings BDC Inc.
Barings BDC Inc operates as a closed-end, non-diversified investment company and has elected to be treated as a business development company. The company's investment objective is to generate current income by investing directly in privately held middle-market companies to help these companies fund acquisitions, growth, or refinancing. It employs fundamental credit analysis and targets investments in businesses with low levels of cyclicality and operating risk relative to other businesses in this market segment. The holding size of each position will generally be dependent upon a number of factors including total facility size, pricing and structure, and the number of other lenders in the facility.